Lake Street Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $13
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and a price target of $13.
April 19, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Lake Street analyst Frank Takkinen has initiated coverage on Cellebrite DI with a Buy rating and set a price target of $13.
The initiation of coverage by Lake Street with a Buy rating and a price target of $13 is a strong positive signal for Cellebrite DI. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100